BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2010
View Archived Issues
Preclinical and clinical data reported on yellow fever vaccine XRX-001
Read More
TG-003 may be beneficial in Duchenne's muscular dystrophy
Read More
V-211 vaccine reduces incidence of shingles in adults aged 50-59 years in phase III trial
Read More
RO-2492 alleviates symptoms of collagen-induced arthritis in mice
Read More
Fosfomycin/tobramycin improves lung function in patients with CF and lung infections
Read More
Omeros identifies GPR87 receptor antagonist that potentiates doxorubicin activity
Read More
Pfizer offers overview of third quarter 2010
Read More
Biovista and Pfizer partner to identify new indications for Pfizer drug candidates
Read More
Merck & Co. reviews quarterly developments
Read More
Pfizer begins phase I trial of PF-05230905
Read More
Palatin Technologies receives grants from U.S. government to support development of four projects
Read More
Merck & Co. describes new phosphodiesterase 10A inhibitors
Read More
Novartis presents new HCV NS3/NS4A inhibitors
Read More
Bristol-Myers Squibb discovers new inhibitors of HCV NS5A
Read More
Actelion Pharma discloses new P2Y12 receptor antagonists
Read More
Pozen projects are selected for federal grant funding
Read More
Merck KGaA patents new E-NPP 2 inhibitors
Read More
NeuroDerm advances phase IIa trial of ND-0801 in ADD/ADHD
Read More
Upsher-Smith Labs begins extension study of USL-255 for partial-onset epilepsy
Read More
Schering-Plough Europe withdraws MAA for Zenhale
Read More
Eusa Pharma submits BLA to FDA for Erwinase in acute lymphoblastic leukemia
Read More
Michael J. Fox Foundation awards grant to Acadia Pharma
Read More
FDA fast track status for Sanofi Pasteur's C. difficile vaccine CdAB
Read More
SuperGen discontinues development of SGI-1776 due to toxicity results
Read More
Watson Pharma plans to discontinue development of Uracyst
Read More